$MSLP Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in MusclePharm Corp.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in MusclePharm Corp. Get notifications about new insider transactions in MusclePharm Corp for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 06 2013 | MSLP | MusclePharm Corp | Estalella Richard | Chief Operating Off ... | Buy | P | 7.90 | 2,000 | 15,800 | 110,000 | 108 K to 110 K (+1.85 %) |
Dec 06 2013 | MSLP | MusclePharm Corp | Estalella Richard | Chief Operating Off ... | Buy | P | 8.05 | 1,600 | 12,880 | 108,000 | 106.4 K to 108 K (+1.50 %) |
Dec 06 2013 | MSLP | MusclePharm Corp | Estalella Richard | Chief Operating Off ... | Buy | P | 8.15 | 3,400 | 27,710 | 106,400 | 103 K to 106.4 K (+3.30 %) |
Dec 06 2013 | MSLP | MusclePharm Corp | Gregory Cory J | See Remarks | Grant | A | 7.80 | 32 | 250 | 308,890 | 308.9 K to 308.9 K (+0.01 %) |
Dec 06 2013 | MSLP | MusclePharm Corp | Gregory Cory J | See Remarks | Grant | A | 7.79 | 200 | 1,558 | 308,858 | 308.7 K to 308.9 K (+0.06 %) |
Dec 05 2013 | MSLP | MusclePharm Corp | DAVIS LEWIS GARY | Chief Financial Off ... | Buy | P | 8.15 | 1,000 | 8,150 | 222,678 | 221.7 K to 222.7 K (+0.45 %) |
Dec 05 2013 | MSLP | MusclePharm Corp | DAVIS LEWIS GARY | Chief Financial Off ... | Buy | P | 7.79 | 1,000 | 7,790 | 221,678 | 220.7 K to 221.7 K (+0.45 %) |
Dec 05 2013 | MSLP | MusclePharm Corp | Pyatt Brad J | Chief Executive Off ... | Buy | P | 8.30 | 1,000 | 8,300 | 540,722 | 539.7 K to 540.7 K (+0.19 %) |
Dec 05 2013 | MSLP | MusclePharm Corp | Pyatt Brad J | Chief Executive Off ... | Buy | P | 8.17 | 500 | 4,085 | 539,722 | 539.2 K to 539.7 K (+0.09 %) |
Dec 05 2013 | MSLP | MusclePharm Corp | Pyatt Brad J | Chief Executive Off ... | Buy | P | 8.10 | 5,100 | 41,310 | 539,222 | 534.1 K to 539.2 K (+0.95 %) |
Dec 05 2013 | MSLP | MusclePharm Corp | Pyatt Brad J | Chief Executive Off ... | Buy | P | 8.05 | 600 | 4,830 | 534,122 | 533.5 K to 534.1 K (+0.11 %) |
Dec 05 2013 | MSLP | MusclePharm Corp | Pyatt Brad J | Chief Executive Off ... | Buy | P | 8.01 | 900 | 7,209 | 533,522 | 532.6 K to 533.5 K (+0.17 %) |
Dec 05 2013 | MSLP | MusclePharm Corp | Pyatt Brad J | Chief Executive Off ... | Buy | P | 7.95 | 2,200 | 17,490 | 532,622 | 530.4 K to 532.6 K (+0.41 %) |
Dec 05 2013 | MSLP | MusclePharm Corp | Pyatt Brad J | Chief Executive Off ... | Buy | P | 7.94 | 454 | 3,605 | 530,422 | 530 K to 530.4 K (+0.09 %) |
Dec 05 2013 | MSLP | MusclePharm Corp | Pyatt Brad J | Chief Executive Off ... | Buy | P | 7.70 | 800 | 6,160 | 529,968 | 529.2 K to 530 K (+0.15 %) |
Dec 05 2013 | MSLP | MusclePharm Corp | Gregory Cory J | See Remarks | Grant | A | 7.95 | 400 | 3,180 | 308,658 | 308.3 K to 308.7 K (+0.13 %) |
Dec 05 2013 | MSLP | MusclePharm Corp | Gregory Cory J | See Remarks | Grant | A | 8.02 | 2,000 | 16,040 | 308,258 | 306.3 K to 308.3 K (+0.65 %) |
Dec 05 2013 | MSLP | MusclePharm Corp | Gregory Cory J | See Remarks | Grant | A | 8.05 | 600 | 4,830 | 306,258 | 305.7 K to 306.3 K (+0.20 %) |
Dec 05 2013 | MSLP | MusclePharm Corp | ROLLOCK SYDNEY R | Chief Marketing Off ... | Buy | P | 8.05 | 6,335 | 50,997 | 14,505 | 8.2 K to 14.5 K (+77.54 %) |
Dec 05 2013 | MSLP | MusclePharm Corp | ROLLOCK SYDNEY R | Chief Marketing Off ... | Buy | P | 8.30 | 2,000 | 16,600 | 8,170 | 6.2 K to 8.2 K (+32.41 %) |
Dec 02 2013 | MSLP | MusclePharm Corp | Pyatt Brad J | Chief Executive Off ... | Buy | P | 8.65 | 100 | 865 | 529,168 | 529.1 K to 529.2 K (+0.02 %) |
Dec 02 2013 | MSLP | MusclePharm Corp | Pyatt Brad J | Chief Executive Off ... | Buy | P | 8.64 | 2,800 | 24,192 | 529,068 | 526.3 K to 529.1 K (+0.53 %) |
Dec 02 2013 | MSLP | MusclePharm Corp | Pyatt Brad J | Chief Executive Off ... | Buy | P | 8.63 | 200 | 1,726 | 526,268 | 526.1 K to 526.3 K (+0.04 %) |
Dec 02 2013 | MSLP | MusclePharm Corp | Pyatt Brad J | Chief Executive Off ... | Buy | P | 8.50 | 200 | 1,700 | 526,068 | 525.9 K to 526.1 K (+0.04 %) |
Dec 02 2013 | MSLP | MusclePharm Corp | Pyatt Brad J | Chief Executive Off ... | Buy | P | 8.51 | 1,400 | 11,914 | 525,868 | 524.5 K to 525.9 K (+0.27 %) |
Dec 02 2013 | MSLP | MusclePharm Corp | Pyatt Brad J | Chief Executive Off ... | Buy | P | 8.40 | 2,100 | 17,640 | 524,468 | 522.4 K to 524.5 K (+0.40 %) |
Dec 02 2013 | MSLP | MusclePharm Corp | Pyatt Brad J | Chief Executive Off ... | Buy | P | 8.31 | 2,000 | 16,620 | 522,368 | 520.4 K to 522.4 K (+0.38 %) |
Nov 27 2013 | MSLP | MusclePharm Corp | DAVIS LEWIS GARY | Chief Financial Off ... | Buy | P | 8.30 | 200 | 1,660 | 220,678 | 220.5 K to 220.7 K (+0.09 %) |
Nov 27 2013 | MSLP | MusclePharm Corp | DAVIS LEWIS GARY | Chief Financial Off ... | Buy | P | 8.25 | 50 | 413 | 220,478 | 220.4 K to 220.5 K (+0.02 %) |
Nov 27 2013 | MSLP | MusclePharm Corp | DAVIS LEWIS GARY | Chief Financial Off ... | Buy | P | 8.30 | 750 | 6,225 | 220,428 | 219.7 K to 220.4 K (+0.34 %) |
Nov 25 2013 | MSLP | MusclePharm Corp | ROLLOCK SYDNEY R | Chief Marketing Off ... | Buy | P | 8.25 | 5,000 | 41,258 | 6,170 | 1.2 K to 6.2 K (+427.35 %) |
Nov 25 2013 | MSLP | MusclePharm Corp | Estalella Richard | Chief Operating Off ... | Buy | P | 8.30 | 3,000 | 24,900 | 103,000 | 100 K to 103 K (+3.00 %) |
Nov 21 2013 | MSLP | MusclePharm Corp | Pyatt Brad J | Chief Executive Off ... | Buy | P | 8.25 | 950 | 7,838 | 520,368 | 519.4 K to 520.4 K (+0.18 %) |
Nov 21 2013 | MSLP | MusclePharm Corp | Pyatt Brad J | Chief Executive Off ... | Buy | P | 8.10 | 500 | 4,050 | 519,418 | 518.9 K to 519.4 K (+0.10 %) |
Nov 21 2013 | MSLP | MusclePharm Corp | Pyatt Brad J | Chief Executive Off ... | Buy | P | 8.15 | 1,000 | 8,150 | 518,918 | 517.9 K to 518.9 K (+0.19 %) |
Nov 21 2013 | MSLP | MusclePharm Corp | Pyatt Brad J | Chief Executive Off ... | Buy | P | 8.20 | 2,500 | 20,500 | 517,918 | 515.4 K to 517.9 K (+0.49 %) |
Oct 04 2013 | MSLP | MusclePharm Corp | PROSSER DONALD W | Director | Grant | A | 0.00 | 3,125 | 0 | 34,862 | 31.7 K to 34.9 K (+9.85 %) |
Oct 04 2013 | MSLP | MusclePharm Corp | Greenwell James J | Director | Grant | A | 0.00 | 3,125 | 0 | 39,862 | 36.7 K to 39.9 K (+8.51 %) |
Oct 04 2013 | MSLP | MusclePharm Corp | Doron Michael J | Director | Grant | A | 0.00 | 3,125 | 0 | 34,862 | 31.7 K to 34.9 K (+9.85 %) |
Jul 09 2013 | MSLP | MusclePharm Corp | Doron Michael J | Director | Grant | A | 0.00 | 25,000 | 0 | 31,737 | 6.7 K to 31.7 K (+371.09 %) |
Jul 08 2013 | MSLP | MusclePharm Corp | Greenwell James J | Director | Grant | A | 0.00 | 25,000 | 0 | 36,737 | 11.7 K to 36.7 K (+213.00 %) |
Jul 08 2013 | MSLP | MusclePharm Corp | DELUCA JEREMY R. | Co-Pres & Chief Mrk ... | Grant | A | 0.00 | 225,000 | 0 | 368,325 | 143.3 K to 368.3 K (+156.99 %) |
Jul 08 2013 | MSLP | MusclePharm Corp | Gregory Cory J | Executive Vice Pres ... | Grant | A | 0.00 | 150,000 | 0 | 305,658 | 155.7 K to 305.7 K (+96.37 %) |
Jul 08 2013 | MSLP | MusclePharm Corp | PROSSER DONALD W | Director | Grant | A | 0.00 | 25,000 | 0 | 31,737 | 6.7 K to 31.7 K (+371.09 %) |
Jul 08 2013 | MSLP | MusclePharm Corp | Estalella Richard | Chief Operating Off ... | Grant | A | 0.00 | 100,000 | 0 | 100,000 | 0 to 100 K |
Jul 08 2013 | MSLP | MusclePharm Corp | BLUHER JOHN H | EVP - COO | Grant | A | 0.00 | 150,000 | 0 | 193,118 | 43.1 K to 193.1 K (+347.88 %) |
Jul 08 2013 | MSLP | MusclePharm Corp | DAVIS LEWIS GARY | Chief Financial Off ... | Grant | A | 0.00 | 200,000 | 0 | 219,678 | 19.7 K to 219.7 K (+1,016.36 %) |
Jul 08 2013 | MSLP | MusclePharm Corp | Pyatt Brad J | Chief Executive Off ... | Grant | A | 0.00 | 350,000 | 0 | 515,418 | 165.4 K to 515.4 K (+211.59 %) |
Apr 05 2013 | MSLP | MusclePharm Corp | Doron Michael J | Director | Grant | A | 0.00 | 132 | 0 | 6,737 | 6.6 K to 6.7 K (+2.00 %) |
Apr 05 2013 | MSLP | MusclePharm Corp | Doron Michael J | Director | Grant | A | 0.00 | 6,252 | 0 | 6,605 | 353 to 6.6 K (+1,771.10 %) |
Apr 04 2013 | MSLP | MusclePharm Corp | Greenwell James J | Director | Grant | A | 0.00 | 132 | 0 | 6,737 | 6.6 K to 6.7 K (+2.00 %) |
Apr 04 2013 | MSLP | MusclePharm Corp | Greenwell James J | Director | Grant | A | 0.00 | 6,252 | 0 | 6,605 | 353 to 6.6 K (+1,771.10 %) |
Apr 04 2013 | MSLP | MusclePharm Corp | PROSSER DON | Director | Grant | A | 0.00 | 132 | 0 | 6,737 | 6.6 K to 6.7 K (+2.00 %) |
Apr 04 2013 | MSLP | MusclePharm Corp | PROSSER DON | Director | Grant | A | 0.00 | 6,252 | 0 | 6,605 | 353 to 6.6 K (+1,771.10 %) |
Feb 06 2013 | MSLP | MusclePharm Corp | Greenwell James J | Director | Option Exercise | P | 0.00 | 2,500 | 0 | 2,500 | |
Nov 20 2012 | MSLP | MusclePharm Corp | BLUHER JOHN H | EVP - COO | Grant | A | 0.00 | 60,000,000 | 0 | 76,650,000 | 16.7 M to 76.7 M (+360.36 %) |
Nov 20 2012 | MSLP | MusclePharm Corp | BLUHER JOHN H | EVP - COO | Option Exercise | M | 0.01 | 25,000,000 | 250,000 | 0 | |
Nov 20 2012 | MSLP | MusclePharm Corp | BLUHER JOHN H | EVP - COO | Buy | M | 0.00 | 16,650,000 | 0 | 16,650,000 | 0 to 16.7 M |
Nov 20 2012 | MSLP | MusclePharm Corp | BLUHER JOHN H | EVP - COO | Option Exercise | A | 0.01 | 25,000,000 | 250,000 | 25,000,000 | |
Nov 20 2012 | MSLP | MusclePharm Corp | DAVIS LEWIS GARY | Chief Financial Off ... | Grant | A | 0.00 | 50,000,000 | 0 | 50,060,000 | 60 K to 50.1 M (+83,333.33 %) |
Nov 19 2012 | MSLP | MusclePharm Corp | Greenwell James J | Director | Grant | A | 0.00 | 300,000 | 0 | 300,000 | 0 to 300 K |
Nov 19 2012 | MSLP | MusclePharm Corp | Doron Michael J | Director | Grant | A | 0.00 | 300,000 | 0 | 300,000 | 0 to 300 K |
Nov 19 2012 | MSLP | MusclePharm Corp | PROSSER DON | Director | Grant | A | 0.00 | 300,000 | 0 | 300,000 | 0 to 300 K |
Nov 09 2012 | MSLP | MusclePharm Corp | Burr Gordon G | Director | Option Exercise | M | 0.02 | 30,000,000 | 450,000 | 0 | |
Nov 09 2012 | MSLP | MusclePharm Corp | Burr Gordon G | Director | Option Exercise | M | 0.01 | 100,000,000 | 1,200,000 | 0 | |
Nov 09 2012 | MSLP | MusclePharm Corp | Burr Gordon G | Director | Buy | M | 0.00 | 19,980,000 | 0 | 86,580,000 | 66.6 M to 86.6 M (+30.00 %) |
Nov 09 2012 | MSLP | MusclePharm Corp | Burr Gordon G | Director | Buy | M | 0.00 | 66,600,000 | 0 | 66,600,000 | 0 to 66.6 M |
Apr 30 2012 | MSLP | MusclePharm Corp | DELUCA JEREMY R. | Co-Pres. & Chief Mk ... | Buy | P | 0.02 | 500,000 | 9,500 | 148,682,972 | 148.2 M to 148.7 M (+0.34 %) |
Apr 30 2012 | MSLP | MusclePharm Corp | Pyatt Brad J | Chief Executive Off ... | Buy | P | 0.02 | 210,000 | 3,717 | 168,799,287 | 168.6 M to 168.8 M (+0.12 %) |
Apr 30 2012 | MSLP | MusclePharm Corp | Pyatt Brad J | Chief Executive Off ... | Buy | P | 0.02 | 45,000 | 833 | 168,589,287 | 168.5 M to 168.6 M (+0.03 %) |
Apr 30 2012 | MSLP | MusclePharm Corp | Pyatt Brad J | Chief Executive Off ... | Buy | P | 0.02 | 50,000 | 940 | 168,544,287 | 168.5 M to 168.5 M (+0.03 %) |
Apr 30 2012 | MSLP | MusclePharm Corp | Pyatt Brad J | Chief Executive Off ... | Buy | P | 0.02 | 2,000 | 38 | 168,494,287 | 168.5 M to 168.5 M (0.00 %) |
Apr 30 2012 | MSLP | MusclePharm Corp | Pyatt Brad J | Chief Executive Off ... | Buy | P | 0.02 | 40,000 | 752 | 168,492,287 | 168.5 M to 168.5 M (+0.02 %) |
Apr 30 2012 | MSLP | MusclePharm Corp | Pyatt Brad J | Chief Executive Off ... | Buy | P | 0.02 | 100,000 | 1,880 | 168,452,287 | 168.4 M to 168.5 M (+0.06 %) |
Apr 30 2012 | MSLP | MusclePharm Corp | Pyatt Brad J | Chief Executive Off ... | Buy | P | 0.02 | 179,872 | 3,436 | 168,352,287 | 168.2 M to 168.4 M (+0.11 %) |
Apr 30 2012 | MSLP | MusclePharm Corp | Pyatt Brad J | Chief Executive Off ... | Buy | P | 0.02 | 20,128 | 392 | 168,172,415 | 168.2 M to 168.2 M (+0.01 %) |
Apr 30 2012 | MSLP | MusclePharm Corp | Pyatt Brad J | Chief Executive Off ... | Buy | P | 0.02 | 15,000 | 293 | 168,152,287 | 168.1 M to 168.2 M (+0.01 %) |
Apr 30 2012 | MSLP | MusclePharm Corp | Pyatt Brad J | Chief Executive Off ... | Buy | P | 0.02 | 10,000 | 198 | 168,137,287 | 168.1 M to 168.1 M (+0.01 %) |
Apr 26 2012 | MSLP | MusclePharm Corp | Pyatt Brad J | Chief Executive Off ... | Buy | P | 0.02 | 10,000 | 190 | 168,127,287 | 168.1 M to 168.1 M (+0.01 %) |
Apr 26 2012 | MSLP | MusclePharm Corp | Pyatt Brad J | Chief Executive Off ... | Buy | P | 0.02 | 25,000 | 470 | 168,117,287 | 168.1 M to 168.1 M (+0.01 %) |
Apr 26 2012 | MSLP | MusclePharm Corp | Pyatt Brad J | Chief Executive Off ... | Buy | P | 0.02 | 25,000 | 475 | 168,092,287 | 168.1 M to 168.1 M (+0.01 %) |
Apr 26 2012 | MSLP | MusclePharm Corp | Pyatt Brad J | Chief Executive Off ... | Buy | P | 0.02 | 70,000 | 1,295 | 168,067,287 | 168 M to 168.1 M (+0.04 %) |
Apr 26 2012 | MSLP | MusclePharm Corp | Pyatt Brad J | Chief Executive Off ... | Buy | P | 0.02 | 5,000 | 92 | 167,997,287 | 168 M to 168 M (0.00 %) |
Apr 26 2012 | MSLP | MusclePharm Corp | Pyatt Brad J | Chief Executive Off ... | Buy | P | 0.02 | 10,000 | 177 | 167,982,287 | 168 M to 168 M (+0.01 %) |
Apr 26 2012 | MSLP | MusclePharm Corp | Pyatt Brad J | Chief Executive Off ... | Buy | P | 0.02 | 10,000 | 183 | 167,972,287 | 168 M to 168 M (+0.01 %) |
Apr 26 2012 | MSLP | MusclePharm Corp | Pyatt Brad J | Chief Executive Off ... | Buy | P | 0.02 | 1,000,000 | 21,900 | 167,962,287 | 167 M to 168 M (+0.60 %) |
Feb 01 2012 | MSLP | MusclePharm Corp | Gregory Cory J | President | Buy | J | 0.00 | 148,182,971 | 0 | 158,665,985 | 10.5 M to 158.7 M (+1,413.55 %) |
Feb 01 2012 | MSLP | MusclePharm Corp | Pyatt Brad J | Chief Executive Off ... | Buy | J | 0.00 | 148,182,971 | 0 | 166,962,287 | 18.8 M to 167 M (+789.08 %) |
Oct 20 2010 | MSLP | MusclePharm Corp | Pyatt Brad J | Chief Executive Off ... | Buy | J | 0.00 | 5,000,000 | 0 | 17,331,668 | 12.3 M to 17.3 M (+40.55 %) |
Oct 20 2010 | MSLP | MusclePharm Corp | Gregory Cory J | President | Buy | J | 0.00 | 5,000,000 | 0 | 12,833,014 | 7.8 M to 12.8 M (+63.83 %) |
Apr 06 2010 | MSLP | MusclePharm Corp | Armenta Leonard K Jr | Director | Option Exercise | A | 0.50 | 1,000,000 | 500,000 | 1,000,000 |